Cargando…
Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox
Breast cancer is the most commonly diagnosed malignancy in women, and while the survival prognosis of patients with early-stage, non-metastatic disease is ∼75%, recurrence poses a significant risk and advanced and/or metastatic breast cancer is incurable. A distinctive feature of advanced breast can...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693572/ https://www.ncbi.nlm.nih.gov/pubmed/34988459 http://dx.doi.org/10.1093/narcan/zcab048 |